<DOC>
	<DOC>NCT00006275</DOC>
	<brief_summary>OBJECTIVES: I. Determine the therapeutic efficacy and safety of topical calcitriol in children with psoriasis.</brief_summary>
	<brief_title>Study of Topical Calcitriol in Children With Psoriasis</brief_title>
	<detailed_description>PROTOCOL OUTLINE: Patients apply topical calcitriol in petrolatum on a psoriatic lesion daily. Patients also apply petrolatum without calcitriol to another psoriatic lesion daily. Patients have both lesions photographed prior to therapy, monthly during therapy, and at the completion of therapy. Lesions are assessed weekly for 1 month and then every 2 weeks while on study. Blood samples are collected every 1 to 2 months and urine samples are collected every 2 weeks while on study.</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA: Disease Characteristics Diagnosis of psoriasis At least 2 lesions with area at least 3050 cm2 Prior/Concurrent Therapy No other concurrent therapy for psoriasis No concurrent calcium supplements greater than 1,000 mg/day No concurrent prednisone or other drugs affecting serum or urine calcium levels Patient Characteristics Renal: No high blood or urinary calcium levels Other: Not pregnant Negative pregnancy test Fertile patients must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2000</verification_date>
	<keyword>dermatologic disorders</keyword>
	<keyword>psoriasis</keyword>
	<keyword>rare disease</keyword>
</DOC>